vTv Therapeutics SG&A Expense (TTM) Trends

vTv Therapeutics Inc (VTVT)

17.50 -0.78 (-4.27%) USD | NASDAQ | Jul 05, 15:55

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
March 31, 2024	12.40M
December 31, 2023	11.91M
September 30, 2023	11.73M
June 30, 2023	11.82M
March 31, 2023	10.34M
December 31, 2022	12.20M
September 30, 2022	15.53M
June 30, 2022	15.12M
March 31, 2022	15.53M
December 31, 2021	12.34M
September 30, 2021	8.662M
June 30, 2021	7.512M
March 31, 2021	6.965M
December 31, 2020	7.251M
September 30, 2020	7.205M
June 30, 2020	7.904M
March 31, 2020	8.601M
December 31, 2019	8.537M
September 30, 2019	8.621M

Date	Value
June 30, 2019	9.009M
March 31, 2019	9.354M
December 31, 2018	9.223M
September 30, 2018	10.09M
June 30, 2018	10.50M
March 31, 2018	10.76M
December 31, 2017	11.33M
September 30, 2017	10.65M
June 30, 2017	10.48M
March 31, 2017	10.15M
December 31, 2016	9.906M
September 30, 2016	10.02M
June 30, 2016	10.04M
March 31, 2016	9.663M
December 31, 2015	9.077M
September 30, 2015	8.847M
June 30, 2015	8.024M
March 31, 2015	8.585M
December 31, 2014	11.72M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

6.965M

Minimum

Mar 2021

15.53M

Maximum

Sep 2022

10.53M

Average

10.34M

Median

Mar 2023

SG&A Expense (TTM) Benchmarks